Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03VUQ
|
|||
Former ID |
DNC008213
|
|||
Drug Name |
4-(4-hydroxy-benzylideneamino)-benzenesulfonamide
|
|||
Synonyms |
4-(4-hydroxybenzylideneamino)benzenesulfonamide
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H12N2O3S
|
|||
Canonical SMILES |
C1=CC(=CC=C1C=NC2=CC=C(C=C2)S(=O)(=O)N)O
|
|||
InChI |
1S/C13H12N2O3S/c14-19(17,18)13-7-3-11(4-8-13)15-9-10-1-5-12(16)6-2-10/h1-9,16H,(H2,14,17,18)
|
|||
InChIKey |
QEZYWFVOEUVTBF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 66667-58-1
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides. Bioorg Med Chem. 2008 Mar 1;16(5):2697-706. | |||
REF 2 | Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6014-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.